214 related articles for article (PubMed ID: 32323916)
21. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
22. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
[TBL] [Abstract][Full Text] [Related]
23. ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
Redondo Monte E; Wilding A; Leubolt G; Kerbs P; Bagnoli JW; Hartmann L; Hiddemann W; Chen-Wichmann L; Krebs S; Blum H; Cusan M; Vick B; Jeremias I; Enard W; Theurich S; Wichmann C; Greif PA
Oncogene; 2020 Apr; 39(15):3195-3205. PubMed ID: 32115572
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
25. Runx1 downregulates stem cell and megakaryocytic transcription programs that support niche interactions.
Behrens K; Triviai I; Schwieger M; Tekin N; Alawi M; Spohn M; Indenbirken D; Ziegler M; Müller U; Alexander WS; Stocking C
Blood; 2016 Jun; 127(26):3369-81. PubMed ID: 27076172
[TBL] [Abstract][Full Text] [Related]
26. CBFβ and RUNX1 are required at 2 different steps during the development of hematopoietic stem cells in zebrafish.
Bresciani E; Carrington B; Wincovitch S; Jones M; Gore AV; Weinstein BM; Sood R; Liu PP
Blood; 2014 Jul; 124(1):70-8. PubMed ID: 24850758
[TBL] [Abstract][Full Text] [Related]
27. MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO.
Kohrs N; Kolodziej S; Kuvardina ON; Herglotz J; Yillah J; Herkt S; Piechatzek A; Salinas Riester G; Lingner T; Wichmann C; Bonig H; Seifried E; Platzbecker U; Medyouf H; Grez M; Lausen J
PLoS Genet; 2016 Mar; 12(3):e1005946. PubMed ID: 26990877
[TBL] [Abstract][Full Text] [Related]
28. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
Metzeler KH; Bloomfield CD
Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
[TBL] [Abstract][Full Text] [Related]
29. Bone Marrow Morphology Associated With Germline
Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
[TBL] [Abstract][Full Text] [Related]
30. RUNX1 upregulation via disruption of long-range transcriptional control by a novel t(5;21)(q13;q22) translocation in acute myeloid leukemia.
Cheng CK; Wong THY; Wan TSK; Wang AZ; Chan NPH; Chan NCN; Li CK; Ng MHL
Mol Cancer; 2018 Aug; 17(1):133. PubMed ID: 30157851
[TBL] [Abstract][Full Text] [Related]
31. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
[TBL] [Abstract][Full Text] [Related]
32. Different mutant RUNX1 oncoproteins program alternate haematopoietic differentiation trajectories.
Kellaway SG; Keane P; Edginton-White B; Regha K; Kennett E; Bonifer C
Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33397648
[TBL] [Abstract][Full Text] [Related]
33. Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors.
Rodriguez-Perales S; Torres-Ruiz R; Suela J; Acquadro F; Martin MC; Yebra E; Ramirez JC; Alvarez S; Cigudosa JC
Oncogene; 2016 Jan; 35(1):125-34. PubMed ID: 25798834
[TBL] [Abstract][Full Text] [Related]
34. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
[TBL] [Abstract][Full Text] [Related]
35. ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.
Hartmann L; Dutta S; Opatz S; Vosberg S; Reiter K; Leubolt G; Metzeler KH; Herold T; Bamopoulos SA; Bräundl K; Zellmeier E; Ksienzyk B; Konstandin NP; Schneider S; Hopfner KP; Graf A; Krebs S; Blum H; Middeke JM; Stölzel F; Thiede C; Wolf S; Bohlander SK; Preiss C; Chen-Wichmann L; Wichmann C; Sauerland MC; Büchner T; Berdel WE; Wörmann BJ; Braess J; Hiddemann W; Spiekermann K; Greif PA
Nat Commun; 2016 Jun; 7():11733. PubMed ID: 27252013
[TBL] [Abstract][Full Text] [Related]
36. BET inhibition prevents aberrant RUNX1 and ERG transcription in STAG2 mutant leukaemia cells.
Antony J; Gimenez G; Taylor T; Khatoon U; Day R; Morison IM; Horsfield JA
J Mol Cell Biol; 2020 Jun; 12(5):397-399. PubMed ID: 31897485
[No Abstract] [Full Text] [Related]
37. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.
Silva FP; Swagemakers SM; Erpelinck-Verschueren C; Wouters BJ; Delwel R; Vrieling H; van der Spek P; Valk PJ; Giphart-Gassler M
Blood; 2009 Oct; 114(14):3001-7. PubMed ID: 19666867
[TBL] [Abstract][Full Text] [Related]
39. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
[TBL] [Abstract][Full Text] [Related]
40. An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
Wang H; Li W; Guo R; Sun J; Cui J; Wang G; Hoffman AR; Hu JF
Int J Cancer; 2014 Dec; 135(12):2783-94. PubMed ID: 24752773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
